Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2716 of 5804
-
Gadgets vs. dental pain: VR and white noise tested in kids with ADHD
Symptom relief CompletedThe present study aims to assess and compare the effectiveness of different technology-based distraction techniques on pain perception and dental anxiety in children with Attention Deficit/Hyperactivity Disorder during different dental procedures
Phase: NA • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New vaccine combo aims to clear persistent HPV infection
Disease control Recruiting nowPhase I clinical trial to assess safety of pNGVL4aCRTE6E7L2 DNA and TA-CIN protein vaccinations, and to seek the appropriate dose of the pNGVL4aCRTE6E7L2 DNA vaccine
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill targets Hard-to-Treat cancers with MAPK gene flaw
Disease control Recruiting nowThis first-in-human (FIH) study aims to assess the safety, tolerability, pharmacokinetics, and recommended phase 2 dose (RP2D) of D3S-002 given orally daily for 21-day cycles in adult subjects with advanced solid tumors with mitogen-activated protein kinase (MAPK) pathway mutatio…
Phase: PHASE1, PHASE2 • Sponsor: D3 Bio (Wuxi) Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Saline vs. drugs: a simpler way to treat lung infections?
Disease control CompletedParapneumonic effusions caused by an infection of the pleural membranes occur in 40-57% of cases of pneumonia. A variable percentage (10-20%) of parapneumonic effusions progresses to empyema (pus) and/or abscess formation (encapsulation). Pleural infection is associated with sign…
Phase: NA • Sponsor: National University of Malaysia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a Head-Zap and online therapy slow speech loss?
Symptom relief ENROLLING_BY_INVITATIONPrimary progressive aphasia (PPA) is a disorder characterized by gradual decline in speech-language ability caused by underlying neurodegenerative disease. PPA is a devastating condition that can affect adults as young as their 50's, depriving them of the ability to communicate a…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Friends helping friends: new study aims to boost COVID-19 vaccination in latino communities
⭐️ VACCINE ⭐️ Recruiting nowThe goal of this clinical trial is to find out which approach works better in getting more of the friends and connections of Latino adults get vaccinated against COVID-19. The main questions this study aims to answer are: 1. Can teaching people to use motivational interviewing …
Phase: NA • Sponsor: Johns Hopkins University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:57 UTC
-
Can what kids eat during cancer treatment change outcomes? new study aims to find out
Knowledge-focused Recruiting nowOver the last decades, research has shown that poor nutritional status can adversely impact prognosis and increase toxicities during treatment for childhood cancer. EPICkids is a collaboration between the International Initiative for Pediatrics and Nutrition, the International Ag…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Could a higher dose of TB drug save kids with HIV?
Disease control Recruiting nowTuberculosis (TB) is the leading cause of death among children with HIV, yet insufficient data are available on the pharmacokinetics of newer HIV/TB cotreatment strategies in children. Current WHO-recommended rifampicin dosages result in low concentrations in most children, and h…
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Stitch-Free kidney surgery could speed recovery in new trial
Disease control OngoingIntended to minimize ischemia during robotic partial nephrectomy (RPN) procedures "by any means possible". Before starting enucleation, the boundaries of the tumor are marked during SL-ocRPN surgery cautery. Once the tumor is removed, the resection bed is cauterized by dispensin…
Phase: NA • Sponsor: Regina Elena Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Cancer combo trial halted early: what we know
Disease control TerminatedPhase 2, open-label, multicenter, randomized study comparing the safety and efficacy of personalized ultra-fractionated stereotactic adaptive radiotherapy (PULSAR) combined with immune checkpoint inhibitor (ICI) immunotherapy (PULSAR-ICI) + IMSA101 and PULSAR-ICI alone in patient…
Phase: PHASE2 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug SKB410 enters human testing for Hard-to-Treat cancers
Disease control OngoingThis is a multicenter, open-label, multiple-dose dose finding and expansion study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and anti-tumor efficacy of SKB410 for injection in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Teen depression study aims to predict who will respond to antidepressants
Knowledge-focused Recruiting nowDespite the prevalence and significant public health concern over depression among adolescents, up to 40% of depressed adolescents do not respond to first-line antidepressants (herein termed treatment non-response, TNR). The goal of this project is to recruit and assess 160 treat…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a common antioxidant help mitochondrial disease?
Disease control Recruiting nowN-Acetylcysteine (NAC), an anti-oxidant, will be studied to investigate the effects on brain glutathione levels, cognitive skills, motor skills, and quality of life. A group of 18 participants will take either 1800, 3600 or 5400 mg per day of N-acetylcysteine (NAC) for 3 months …
Phase: PHASE1 • Sponsor: Michio Hirano, MD • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New asthma pill shows promise in early trial
Disease control TerminatedRandomized, multi-center, double-blind, placebo-controlled, parallel group, proof of-concept study with RPT193 in subjects with T2-high, moderate-to-severe asthma who are partially controlled on medium or high doses of inhaled corticosteroids (ICS) in combination with long-acting…
Phase: PHASE2 • Sponsor: RAPT Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
IVF breakthrough? lower progesterone dose tested in 1,020 women
Disease control Recruiting nowThis randomized trial was designed as non-inferiority trial aiming to compare ongoing pregnancy rates following LPS with 600 mg/day vs 800 mg/day vaginal VMP. All patients will undergo an artificial cycle frozen embryo transfer (AC-FET) with transdermal estradiol 6mg/day Patients…
Phase: PHASE3 • Sponsor: Fundación Santiago Dexeus Font • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Cancer-Killing virus trial launches for Hard-to-Treat tumors
Disease control OngoingThe goal of this clinical trial is to evaluate the safety, tolerance, pharmacokinetics, and biological properties of recombinant human IL-21-expressing oncolytic vaccinia virus injection (hV01) in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Phone app sends Real-Time coping tips to fight suicidal thoughts
Symptom relief CompletedThe goal of this study is to learn about a new, real-time, smartphone-based intervention aimed to decrease risk for suicide in adults who have been hospitalized for suicidal thoughts or behaviors. The main questions the investigators aim to answer are: * Is a real-time, smartpho…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New study tracks Wegovy's safety in pregnancy
Knowledge-focused ENROLLING_BY_INVITATIONThis is an observational, prospective Wegovy (semaglutide 2.4 milligram \[mg\]) Pregnancy Registry Study. The aim of this study is to compare the maternal, foetal, and infant outcomes of pregnant women who are exposed to Wegovy during pregnancy for the treatment of obesity or ove…
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
NYC study tests whether neighbors can boost cancer screening
Knowledge-focused Recruiting nowNYC CONNECT will carry out a randomized controlled trial (RCT) which will assess the relative effectiveness of two evidence-based strategies to increase cancer screening rates for breast, cervical, and colorectal cancer. The RCT will compare the effectiveness of using a combinati…
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Ear stimulation device shows promise for Ehlers-Danlos relief
Symptom relief CompletedInvestigate whether at-home transcutaneous auricular VNS (tAN: transcutaneous auricular neurostimulation) improves a battery of nine key physical and psychological symptoms of a group of hEDS (Hypermobile Ehlers-Danlos Syndrome \& Hypermobile Spectrum Disorder) patients (n=30) us…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC